BridgeBio Pharma (BBIO) Stock Price
$36.85 0.1%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
3 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on BridgeBio Pharma, AI stock picks, stock alerts and much more.
BBIO AI Stock Analysis
AI stock analysis for BBIO is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BridgeBio Pharma (BBIO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BridgeBio Pharma (BBIO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BridgeBio Pharma (BBIO), currently trading at $36.85, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BBIO
-
BridgeBio Pharma, Inc.
-
Symbol
BBIO
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
7B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
Crispr Therapeutics CRSP |
$47.91 5% |
6 |
News
BBIO Alternative Data
Web Traffic
BridgeBio Pharma receives an estimated 54343 monthly visitors to bridgebio.com.
-
Web Traffic
54343
-
Change from Previous Month
74.4%
-
3 Month Change
38.1%
-
YoY Change
38.1%
Reddit Mentions
BridgeBio Pharma has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
News Mentions
BridgeBio Pharma was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
48,653 are following BridgeBio Pharma on LinkedIn, up by 3.3% over the last month.
-
LinkedIn Followers
48653
-
Daily Change
0.1%
-
1 Month Change
3.3%
-
3 Month Change
9.8%
Job Postings
BridgeBio Pharma has an estimated 43 open job postings, which is down -4.4% over the last month.
-
Job Postings
43
-
Daily Change
2.3%
-
1 Month Change
4.4%
-
3 Month Change
87%
-
YoY Change
87%
LinkedIn Employees
According to LinkedIn, BridgeBio Pharma has 695 employees, up by 0.3% over the last month.
-
LinkedIn Employees
695
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.9%
-
YoY Change
0.9%
Business Outlook
-
Business Outlook
93
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
BBIO Financials
BBIO Key Metrics
-
Total Revenue
$2.7M
-
Net Income
-$162M
-
Earnings per Share
-$0.86
-
Free cash flow
-$182.3M
-
EBITDA
-$139.7M
-
EBITDA Ratio
-51.1182
-
Total Assets
$665M
BBIO 2-year Revenue & Income
BBIO 2-year Free Cash Flow
BBIO Technicals
BBIO SMA
BBIO RSI
FAQ
What's the current price of BridgeBio Pharma (BBIO) Stock?
The price of an BridgeBio Pharma (BBIO) share is $36.85.
What's the market cap of BridgeBio Pharma?
The current market cap of BridgeBio Pharma is 7B.
Should I buy or sell BBIO?
BridgeBio Pharma shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, BridgeBio Pharma is better viewed as a hold or accumulate position while waiting for further developments.
Is BridgeBio Pharma a good investment?
The current analysis of BridgeBio Pharma's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in BridgeBio Pharma's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy BridgeBio Pharma (BBIO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for BridgeBio Pharma stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to BridgeBio Pharma (BBIO) that investors often compare it to?
BridgeBio Pharma (BBIO) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and Crispr Therapeutics.
What is the forecast for BridgeBio Pharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BridgeBio Pharma's stock price to be around $38.32 in 2026. Starting from the current price of $36.85, this represents a 4% change in price, indicating a neutral outlook for the stock.
How to buy BridgeBio Pharma (BBIO) Stock?
BridgeBio Pharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BridgeBio Pharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.